Etrasimod: Completion of enrollment of P3 ELEVATE UC 52 trial (NCT03945188) for ulcerative colitis in H2 2020 (Arena) - Jun 4, 2020 - Corporate Presentation: Data from P3 ELEVATE UC 12 trial (NCT03996369) for ulcerative colitis in H2 2021
Enrollment status • P3 data • Inflammatory Bowel Disease • Ulcerative Colitis
|